BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 865 filers reported holding BAXTER INTL INC in Q3 2015. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $120,000 | -99.7% | 1,841 | -99.7% | 0.00% | -99.6% |
| Q4 2017 | $40,106,000 | -90.8% | 620,450 | -91.1% | 0.28% | -91.8% |
| Q3 2017 | $436,817,000 | +5.4% | 6,961,219 | +1.7% | 3.39% | -1.9% |
| Q2 2017 | $414,476,000 | +18.8% | 6,846,307 | +1.7% | 3.46% | +8.9% |
| Q1 2017 | $349,006,000 | +16.1% | 6,729,772 | -0.7% | 3.18% | +8.1% |
| Q4 2016 | $300,562,000 | -4.5% | 6,778,557 | +2.5% | 2.94% | -10.1% |
| Q3 2016 | $314,756,000 | +3.6% | 6,612,524 | -1.6% | 3.27% | -0.8% |
| Q2 2016 | $303,774,000 | +12.4% | 6,717,677 | +2.1% | 3.29% | +5.0% |
| Q1 2016 | $270,330,000 | +8.3% | 6,580,564 | +0.6% | 3.14% | +4.2% |
| Q4 2015 | $249,566,000 | +46.7% | 6,541,706 | +26.3% | 3.01% | +41.8% |
| Q3 2015 | $170,084,000 | -24.6% | 5,177,603 | +60.5% | 2.12% | -20.0% |
| Q2 2015 | $225,592,000 | +52608.4% | 3,225,972 | +51515.6% | 2.66% | +53000.0% |
| Q1 2015 | $428,000 | -53.3% | 6,250 | -50.0% | 0.01% | -16.7% |
| Q4 2014 | $916,000 | +100.9% | 12,500 | +96.9% | 0.01% | 0.0% |
| Q3 2014 | $456,000 | -95.9% | 6,350 | -95.9% | 0.01% | -95.9% |
| Q2 2014 | $11,070,000 | -92.3% | 153,108 | -92.1% | 0.15% | -92.9% |
| Q1 2014 | $143,389,000 | +8.5% | 1,948,745 | +2.5% | 2.08% | -1.1% |
| Q4 2013 | $132,168,000 | +28.5% | 1,900,328 | +21.3% | 2.10% | +2.0% |
| Q3 2013 | $102,891,000 | +25.9% | 1,566,314 | +32.8% | 2.06% | -8.2% |
| Q2 2013 | $81,701,000 | – | 1,179,457 | – | 2.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |